MedPath

TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)

Recruiting
Conditions
Crohn Disease
Registration Number
NCT05903066
Lead Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Brief Summary

Multicenter prospective cross-sectional study of CD patients, its aim is the construction of an objective and reproducible system for evaluation of Transmural healing in Crohn's Disease (CD).

Primary objective : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD

Detailed Description

Number of patients : 210 patients, in 14 sites (only one investigator per site), 15 patients per site, 5 patients per grade of transmural healing based on the appraisal of a local reader pair (a gastroenterologist and a radiologist).

Recruitment period : 2 years

Primary Endpoint : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD

Secondary Endpoints :

* To analyze intra- and inter-observer variability of radiological findings.

* To analyze intra- and inter-observer variability of TH definitions in CD.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
210
Inclusion Criteria
  • ≥ 18 years of age
  • Patient diagnosed with CD for more than 6 months with histological confirmation available in his medical record.
  • Indication for MRE based on routine clinical practice validated by the treating physician
  • Any CD treatment will be authorized, such as biologicals (infliximab, adalimumab, vedolizumab, ustekinumab...), or immunomodulators (azathioprine, 6-mercaptopurine, methotrexate...).
  • The subjects sign and date a written, informed consent form and any required privacy authorization prior to the initiation of the study.
  • A subject can be enrolled into the study only if the grade of TH (assessed by the LRP) corresponding to the subject is not already fulfilled.
Exclusion Criteria
  • Pregnancy during the study
  • People unable to give consent (because of their physical or mental state)
  • Absence of written consent
  • Ulcerative colitis or unclassified IBD
  • Specific postsurgical settings: ileoanal anastomosis, ileostomy or colostomy.
  • Less than 3 evaluable ileocolic segments or more than 3 resected ileocolonic segments (not counting ileocecal valve)
  • Severe obstructive symptoms
  • Symptomatic intra-abdominal abscess
  • Contraindication for MRI
  • Isolated perianal disease without luminal location
  • MRE images of poor quality, based on previously defined criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CDDay 1

An index (depth of remission) or score (grade of remission) will be constructed through multiple linear or logistic mixed regression models.

Secondary Outcome Measures
NameTimeMethod
Intra- and inter-observer variability of depth and grade of global transmural healing in CDDay 1

Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items.

Intra- and inter-observer variability of lesions observed per segment during MRE in CDDay 1

Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items.

Trial Locations

Locations (18)

CHU de Liège

🇧🇪

Liège, Belgium

APHP - Hôpital Louis Mourier

🇫🇷

Colombes, France

AP-HM - Hôpital Nord

🇫🇷

Marseille, France

CHU de Nîmes - Hôpital Carémeau

🇫🇷

Nîmes, France

Hospices Civils de Lyon

🇫🇷

Pierre-Bénite, France

APHP - Hôpital Ambroise Paré

🇫🇷

Boulogne-Billancourt, France

CHU Amiens-Picardie (site Sud)

🇫🇷

Amiens, France

CHU de Bordeaux - Hôpital Haut-Lévêque

🇫🇷

Bordeaux, France

CHU de Clermont-Ferrand - Hôpital d'Estaing

🇫🇷

Clermont-Ferrand, France

CHRU de Lille - Hôpital Claude Huriez

🇫🇷

Lille, France

CHU Limoges Dupuytren

🇫🇷

Limoges, France

CHU de Montpellier - Hôpital Saint Eloi

🇫🇷

Montpellier, France

CHU de Nantes

🇫🇷

Nantes, France

CHU de Nice - Hôpital l'Archet II

🇫🇷

Nice, France

APHP - Hôpital Européen Georges Pompidou (HEGP)

🇫🇷

Paris, France

CHU Rennes - Hôpital Pontchaillou

🇫🇷

Rennes, France

CHU de Saint Etienne - Hôpital Nord

🇫🇷

Saint-Priest-en-Jarez, France

CHRU de Nancy - Hôpitaux de Brabois

🇫🇷

Vandœuvre-lès-Nancy, France

© Copyright 2025. All Rights Reserved by MedPath